January 19 | 2023
2cureX announces final results regarding 2022 goals
Read more
November 24 | 2022
2cureX publishes interim report for the third quarter and first nine months of 2022
Read more
November 14 | 2022
2cureX discloses status of 2022 plans, goals for 2023 and its estimates of potential market development in the coming years
Read more
September 29 | 2022
2cureX terminates liquidity provision service
Read more
August 25 | 2022
2cureX publishes interim report for the second quarter and first half of 2022
Read more
August 25 | 2022
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2022
Read more
August 8 | 2022
Announcement from 2cureX extra general meeting
Read more
August 8 | 2022
Kommuniké från extra bolagsstämma i 2cureX
Read more
July 20 | 2022
Notice of extra general meeting in 2cureX AB
Read more
July 20 | 2022
Kallelse till extra bolagsstämma i 2curex AB
Read more
May 24 | 2022
Kommuniké från årsstämma i 2cureX AB
Read more
May 24 | 2022
2cureX publishes interim report for the first quarter 2022
Read more
May 24 | 2022
2cureX offentliggör delårsrapport för det första kvartalet 2022
Read more
May 12 | 2022
2cureX AB nominates Dr. Michael Schaefer to the Board of Directors
Read more
May 12 | 2022
2cureX AB nominerar Dr. Michael Schaefer till styrelsen
Read more
May 6 | 2022
2cureX appoints Sedermera Corporate Finance AB to act as a liquidity provider for the Company´s share
Read more
May 6 | 2022
2cureX utser Sedermera Corporate Finance AB till likviditetsgarant för bolagets aktie
Read more
May 3 | 2022
2cureX publishes the annual report for the fiscal year 2021
Read more